Regulations.gov document
Appendix 2 -Label differences between the pioneer, Vetmedin® 1.25 mg, 2.5 mg, 5 mg & 10 mg…
Supporting & Related Material · FDA-2023-P-2583 · posted Jun 23, 2023
Key facts
| Document ID | FDA-2023-P-2583-0005 |
|---|---|
| Title | Appendix 2 -Label differences between the pioneer, Vetmedin® 1.25 mg, 2.5 mg, 5 mg & 10 mg (pimobendan) Chewable Tablets [NADA 141-273, Boehringer Ingelheim Vetmedica, Inc.] and the proposed generic, Pimobendan 5 mg/mL Oral Suspension [Norbrook Laboratories Ltd] RE Suitability Petition from Norbrook Laboratories Limited |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2023-P-2583 |
| Posted | Jun 23, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: